Lv6
3180 积分 2025-04-09 加入
Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy
1个月前
已关闭
First-in-Class Quinoline-Dione-Derived PROTACs: Potent Degraders of Cdc25 Phosphatases for Antitumor Therapy
1个月前
已完结
Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-κB pathway activation
2个月前
已关闭
Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer Immunotherapy
2个月前
已完结
Designing an Osmium(II) Complex to Inhibit the Growth and Recurrence of Tumors by Integrating Photodynamic Therapy, Chemotherapy, and Immunotherapy
2个月前
已完结
PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity
3个月前
已完结
Navigating gene expression using microarrays — a technology review
3个月前
已完结
Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes
3个月前
已完结
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy
4个月前
已完结
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy
4个月前
已完结
皖公网安备34019202002308
